Home/Filings/4/0000091440-25-000073
4//SEC Filing

Pagliari Aldo John 4

Accession 0000091440-25-000073

CIK 0000091440other

Filed

Aug 14, 8:00 PM ET

Accepted

Aug 15, 4:51 PM ET

Size

47.8 KB

Accession

0000091440-25-000073

Insider Transaction Report

Form 4
Period: 2025-08-14
Pagliari Aldo John
SVP-Finance & CFO
Transactions
  • Sale

    Common Stock

    2025-08-15$325.21/sh125$40,651111,721.467 total
  • Sale

    Common Stock

    2025-08-14$329.84/sh100$32,984111,767.467 total
  • Sale

    Common Stock

    2025-08-14$331.54/sh100$33,154111,667.467 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-08-146,82110,179 total
    Exercise: $138.03Exp: 2026-02-11Common Stock (6,821 underlying)
  • Sale

    Common Stock

    2025-08-14$325.99/sh1,931$629,478114,467.467 total
  • Sale

    Common Stock

    2025-08-14$329.01/sh784$257,948111,967.467 total
  • Exercise/Conversion

    Common Stock

    2025-08-14$138.03/sh+6,821$941,503116,398.467 total
  • Exercise/Conversion

    Common Stock

    2025-08-15$138.03/sh+179$24,707111,846.467 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-08-1517910,000 total
    Exercise: $138.03Exp: 2026-02-11Common Stock (179 underlying)
  • Sale

    Common Stock

    2025-08-14$326.75/sh500$163,377113,967.467 total
  • Sale

    Common Stock

    2025-08-14$328.07/sh1,216$398,928112,751.467 total
  • Sale

    Common Stock

    2025-08-14$329.83/sh100$32,983111,867.467 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $189.89Exp: 2031-02-11Common Stock (14,986 underlying)
    14,986
  • Stock Option (Right to Buy)

    Exercise: $249.26From: 2024-02-09Exp: 2033-02-09Common Stock (7,850 underlying)
    7,850
  • Restricted Stock Units

    From: 2026-02-09Exp: 2026-02-09Common Stock (1,793 underlying)
    1,793
  • Performance Units

    Common Stock (2,498 underlying)
    2,498
  • Stock Option (Right to Buy)

    Exercise: $161.18Exp: 2028-02-15Common Stock (26,052 underlying)
    26,052
  • Stock Option (Right to Buy)

    Exercise: $155.34Exp: 2030-02-13Common Stock (23,500 underlying)
    23,500
  • Stock Option (Right to Buy)

    Exercise: $211.67Exp: 2032-02-10Common Stock (11,252 underlying)
    11,252
  • Stock Option (Right to Buy)

    Exercise: $339.73From: 2026-02-13Exp: 2035-02-13Common Stock (5,342 underlying)
    5,342
  • Restricted Stock Units

    From: 2027-02-15Exp: 2027-02-15Common Stock (1,533 underlying)
    1,533
  • Stock Option (Right to Buy)

    Exercise: $155.92Exp: 2029-02-14Common Stock (23,500 underlying)
    23,500
  • Stock Option (Right to Buy)

    Exercise: $269.00From: 2025-02-15Exp: 2034-02-15Common Stock (7,106 underlying)
    7,106
  • Performance Units

    Common Stock (3,586 underlying)
    3,586
  • Performance Units

    Common Stock (3,065 underlying)
    3,065
  • Stock Option (Right to Buy)

    Exercise: $168.70Exp: 2027-02-09Common Stock (36,000 underlying)
    36,000
  • Restricted Stock Units

    From: 2028-02-13Exp: 2028-02-13Common Stock (1,249 underlying)
    1,249
Footnotes (14)
  • [F1]The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on October 22, 2024.
  • [F10]1 for 1.
  • [F11]The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment.
  • [F12]If the Company achieves certain goals over the 2023-2025 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
  • [F13]If the Company achieves certain goals over the 2024-2026 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
  • [F14]If the Company achieves certain goals over the 2025-2027 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
  • [F2]Includes 17.6899 shares acquired under a dividend reinvestment plan.
  • [F3]This transaction was executed in multiple trades at prices ranging from $325.52 to $326.515. The price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
  • [F4]This transaction was executed in multiple trades at prices ranging from $326.59 to $327.04. The price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
  • [F5]This transaction was executed in multiple trades at prices ranging from $327.67 to $328.57. The price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
  • [F6]This transaction was executed in multiple trades at prices ranging from $328.67 to $329.22. The price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
  • [F7]Option fully vested.
  • [F8]Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on October 22, 2024.
  • [F9]Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column.

Issuer

Snap-on Inc

CIK 0000091440

Entity typeother

Related Parties

1
  • filerCIK 0001486096

Filing Metadata

Form type
4
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 4:51 PM ET
Size
47.8 KB